Vitamin C buyers certified to bring class action suit against Chinese pharma companies
U.S. District Judge Brian M. Cogan certified a class of Vitamin C buyers to bring a price-fixing suit against Chinese pharmaceutical companies. The defendants North China Pharmaceutical Co., Aland (Jiangsu) Nutraceutical Co., Northeast Pharmaceutical Co. and Weisheng Pharmaceutical Co. were found to have more than 60 percent world market share for Vitamin C.
New Jersey food company Ranis Co. was appointed to represent the group seeking damages. Texas maker of animal feed additives Animal Science Products Inc. is the class representative for the group requesting an injunction.
Source: Bloomberg
Related content: Duking It Out in Antitrust Price-Fixing: Class Actions After Dukes (Jay Himes & William Reiss, Labaton Sucharow)
Featured News
FTC Files Suit Against Liquor Giant Southern Glazer’s Over Discount Disparities
Dec 12, 2024 by
CPI
Racing Rivals Accuse NASCAR of Retaliation in High-Stakes Antitrust Battle
Dec 12, 2024 by
CPI
Samsung Challenges Indian Antitrust Investigation, Calls Raid “Unlawful”
Dec 12, 2024 by
CPI
European Sites Criticize Google’s Compliance Efforts with DMA
Dec 12, 2024 by
CPI
Banco BPM Overcomes Regulatory Hurdle in $1.7 Billion Bid
Dec 12, 2024 by
CPI
Antitrust Mix by CPI
Coopetition in The Pharma Industry: Challenges for Antitrust
Dec 12, 2024 by
Juan Delgado & Lourdes Sosa
Symmetry and the Sixth Force: The Essential Role of Complements
Dec 12, 2024 by
Adam Brandenburger & Barry Nalebuff
ESG Collaborations in Light of European Antitrust Policy and Enforcement Trends
Dec 12, 2024 by
Christian Ritz, Julia Gingelmaier & Kyra Harmes
Antitrust Chronicle® – Co-opetition
Dec 11, 2024 by
CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI